Acrivon Therapeutics, Inc.

Develops precision cancer therapies by matching patients to drugs using its proteomics platform.

ACRV | US

Overview

Corporate Details

ISIN(s):: US0048901096
LEI:
Country:: United States of America
Address:: 480 ARSENAL WAY, SUITE 100, 2472 WATERTOWN
Website:: https://acrivon.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in precision oncology. The company leverages its proprietary Acrivon Predictive Precision Proteomics (AP3) platform to develop targeted cancer therapies. The AP3 platform utilizes phosphoproteomics to analyze the biologic drivers of a patient's cancer, enabling the creation of predictive 'OncoSignature' tests. This method is designed to match drug candidates with patients whose tumors are most likely to respond, aiming to improve therapeutic outcomes beyond what is achievable with genomics. Acrivon's pipeline is led by ACR-368, a selective kinase inhibitor in Phase 2 clinical trials for various solid tumors. The company also advances its internally developed programs and seeks strategic partnerships to apply its AP3 platform to co-develop predictive tests for external drug candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Acrivon Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Acrivon Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Acrivon Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
ROXX, Inc. HR tech platform connecting non-desk job seekers with full-time roles using AI and vetting tools.	Japan	241A
SAFTEC CO.,LTD. Rents and sells safety equipment for construction, from basic supplies to AI/IoT solutions.	Japan	7464
Salarius Pharmaceuticals, Inc. Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.	United States of America	SLRX
Saniona Develops ion channel medicines for rare neurological diseases and epilepsy.	Denmark	SANION
Santech Holdings Ltd A technology company developing innovative consumer and enterprise technology businesses.	United States of America	STEC
SBI Leasing Services Co.,Ltd. Structures Japanese Operating Leases for aircraft & ships for corporate investors.	Japan	5834
Schrodinger, Inc. A physics-based computational platform for accelerated drug and materials discovery.	United States of America	SDGR
Sensorion Developing gene therapies and small molecules to restore, treat, and prevent hearing loss.	France	ALSEN
SERENDIP HOLDINGS Co.,Ltd. Consulting & investment firm aiding manufacturing SMEs with M&A, succession, and revitalization.	Japan	7318
SEYFERT LTD. Provides recruitment, staffing, and education services for the beauty salon industry.	Japan	9213